TNF-alpha gene polymorphism and plasma TNF-alpha levels are related to lumbar spine bone area in healthy female Caucasian adolescents.

OBJECTIVE The cytokine tumor necrosis factor alpha (TNF-alpha) is an important regulator of bone metabolism. Polymorphisms in the promoter region of the TNF-alpha gene at positions -308 and -863 have been identified. We investigated whether these polymorphisms and circulating TNF-alpha levels were related to bone mineral density and bone area in adolescent girls. DESIGN Bone mineral density (BMD), bone area (BA), anthropometric characteristics and biochemical analyses were measured in adolescent girls and compared with regard to TNF-alpha genotype. METHODS Allelic variants of the TNF-alpha gene in 97 girls, aged 16.9+/-1.2 years (mean+/-S.D.), were identified using polymerase chain reaction and the restriction endonucleases NcoI and TaiI. Bone mineral density and bone area of the femoral neck, lumbar spine and total body were measured using dual energy X-ray absorptiometry. RESULTS Carriers of the rare -863 A allele (n=25) had higher body weight (P=0.03), lumbar spine BMD (P=0.02), and larger total BA (P=0.03), femoral neck area (P<0.05), and lumbar spine area (P=0.01). The independent predictors of BMD and BA were investigated using multiple regression. The TNF-alpha-863 genotypes (beta=0.18, P=0.03) and the TNF-alpha plasma levels (beta=0.19, P=0.04) independently predicted BA of the lumbar spine but not BA or BMD of any other measured sites. No statistically significant differences in body constitution parameters, biochemical parameters, bone density, or bone area at the measured skeletal sites were found when comparing the groups defined by the allelic variants at position -308 (P=0.17-0.84). CONCLUSIONS We found the TNF-alpha-863 polymorphism and the TNF-alpha plasma levels to be independent predictors of lumbar spine area in healthy Caucasian adolescent females.

[1]  A. Tenenhouse,et al.  Association of a Polymorphism in the TNFR2 Gene with Low Bone Mineral Density , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[2]  T. Martin,et al.  Tumor Necrosis Factor (cid:97) Stimulates Osteoclast Differentiation by a Mechanism Independent of the ODF/RANKL–RANK Interaction , 2022 .

[3]  T. Nakajima,et al.  Linkage of human tumor necrosis factor-alpha to human osteoporosis by sib-pair analysis , 2000, Genes and Immunity.

[4]  J. Gustafsson,et al.  Estradiol repression of tumor necrosis factor-alpha transcription requires estrogen receptor activation function-2 and is enhanced by coactivators. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[5]  A. Parfitt,et al.  Vertebral Bone Mass, Size, and Volumetric Density in Women with Spinal Fractures , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[6]  A. Hamsten,et al.  A Common Functional Polymorphism (C→A Substitution at Position −863) in the Promoter Region of the Tumour Necrosis Factor-α (TNF-α) Gene Associated With Reduced Circulating Levels of TNF-α , 1999 .

[7]  B. Beutler,et al.  The role of tumor necrosis factor in health and disease. , 1999, The Journal of rheumatology. Supplement.

[8]  S. Teitelbaum,et al.  Tumor Necrosis Factor-α Mediates Orthopedic Implant Osteolysis , 1999 .

[9]  R. Lorentzon,et al.  Type of Physical Activity, Muscle Strength, and Pubertal Stage as Determinants of Bone Mineral Density and Bone Area in Adolescent Boys , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[10]  C. Mautalen,et al.  Bone Mineral Density and Bone Size in Men With Primary Osteoporosis and Vertebral Fractures , 1998, Calcified Tissue International.

[11]  D. Graves,et al.  IL-1 and TNF antagonists inhibit the inflammatory response and bone loss in experimental periodontitis. , 1998, Journal of immunology.

[12]  R. Rizzoli,et al.  Transgenic mice expressing soluble tumor necrosis factor-receptor are protected against bone loss caused by estrogen deficiency. , 1997, The Journal of clinical investigation.

[13]  R. Heaney,et al.  Bone Dimensional Change with Age: Interactions of Genetic, Hormonal, and Body Size Variables , 1997, Osteoporosis International.

[14]  O. Johnell,et al.  World-wide Projections for Hip Fracture , 1997, Osteoporosis International.

[15]  Roberto Pacifici,et al.  Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis , 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[16]  J. Sayre,et al.  Vertebral size in elderly women with osteoporosis. Mechanical implications and relationship to fractures. , 1995, The Journal of clinical investigation.

[17]  G. Duff,et al.  Genetics of tumour necrosis factor-alpha in autoimmune, infectious, and neoplastic diseases. , 1995, Journal of inflammation.

[18]  H. Northoff,et al.  The cytokine response to strenuous exercise. , 1994, International journal of sports medicine.

[19]  E. Orwoll,et al.  Precision of dual‐energy x‐ray absorptiometry: Development of quality control rules and their application in longitudinal studies , 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[20]  U. Lerner,et al.  Tumor necrosis factors α and β can stimulate bone resorption in cultured mouse calvariae by a Prostaglandin‐independent mechanism , 1993 .

[21]  S. Cummings,et al.  Bone density at various sites for prediction of hip fractures , 1993, The Lancet.

[22]  A. Blakemore,et al.  Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by NcoI restriction of PCR product. , 1992, Human molecular genetics.

[23]  Claus Christiansen,et al.  Diagnosis of Osteoporosis , 1992, Southern medical journal.

[24]  B. Riggs,et al.  Production of various cytokines by normal human osteoblast-like cells in response to interleukin-1 beta and tumor necrosis factor-alpha: lack of regulation by 17 beta-estradiol. , 1992, Endocrinology.

[25]  R. Rizzoli,et al.  Critical years and stages of puberty for spinal and femoral bone mass accumulation during adolescence. , 1991, The Journal of clinical endocrinology and metabolism.

[26]  C. Slemenda,et al.  Genetic determinants of bone mass in adult women: A reevaluation of the twin model and the potential importance of gene interaction on heritability estimates , 1991, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[27]  J. Hopper,et al.  Reduced bone mass in daughters of women with osteoporosis. , 1989, The New England journal of medicine.

[28]  C. Chenu,et al.  Interleukin‐1 and tumor necrosis factor stimulate the formation of human osteoclastlike cells in vitro , 1989, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[29]  J. Willis Atomic Absorption Spectrometry , 1970 .